Achieve Life Sciences Inc. – Material Contracts Watch

from 10-K/A 10 pages Employment Agreement

from 8-K 22 pages Registration Rights Agreement

from 8-K 48 pages Securities Purchase Agreement

from 10-K 6 pages Consulting Agreement

from 10-K 9 pages Amended and Restated Employment Agreement

from 10-Q 24 pages Achieve Pharma Uk Limited May 9, 2025

from 10-K 10 pages Renewal Service Agreement Agreement Date: October 25, 2024

from 10-K 10 pages Employment Agreement

from 10-Q 12 pages Employment Agreement

from 10-Q 15 pages John Bencich Re: Terms of Separation Dear John: This Letter Confirms the Agreement (“Agreement”) Between You and Achieve Life Sciences, Inc. (The “Company”) Concerning the Terms of Your Separation and Offers You the Compensation We Discussed in Exchange for a General Release of Claims and Covenant Not to Sue. 1. Separation Date: August 21, 2024 Is Your Last Day of Employment With the Company (The “Separation Date”). 2. Resignation From Officer Positions and Board Membership: Effective as of August 21, 2024, You Hereby Resign From All Officer and Board of Director Positions With the Company and All Subsidiaries Thereof, Without the Need of Acceptance or Any Further Action by the Company. 3

from 8-K 24 pages Registration Rights Agreement

from 8-K 73 pages 2024 Contingent Convertible Debt Agreement

from 10-K 10 pages Renewal Service Agreement Agreement Date: November 9, 2023

from 10-K 20 pages Dated 14 May 2015 (1) Extab Pharma, Inc. and (2) Sopharma Ad Share Purchase Agreement 1 Contents

from 10-K 7 pages Indemnification Agreement

from 8-K 43 pages Securities Purchase Agreement

from 8-K 35 pages Securities Purchase Agreement

from 8-K 24 pages Registration Rights Agreement

from 8-K 75 pages 2023 Contingent Convertible Debt Agreement

from 8-K 4 pages Achieve Life Sciences, Inc. 1040 West Georgia Street, Suite 1030 Vancouver, Bc V6e 4h1